Health Information Exchange Platform for Improving Patient Transfers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve how hospitals share critical patient information during transfers, reducing medical errors and enhancing patient safety. Researchers will test a new digital system, the Health Information Exchange (HIE) platform, which helps hospitals access and manage patient records more effectively during patient transfers. The system will undergo testing in three different hospital scenarios to evaluate its effectiveness. Patients transferred from specific hospitals and admitted to services like general medicine or cardiology may qualify for this trial. As an unphased trial, this study offers patients the chance to contribute to innovative solutions that enhance healthcare safety and efficiency.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this health information exchange platform is safe for improving patient transfers?
Research has shown that health information technology, such as the Health Information Exchange (HIE) platform, can enhance healthcare safety by reducing medication errors and adverse drug effects. The platform is generally safe as it manages medical records rather than interacting directly with patients.
Additionally, studies indicate that HIE platforms improve the sharing of patient information among hospitals. Better communication between hospitals leads to fewer medical errors, suggesting the platform is safe due to its role in enhancing information sharing without directly impacting patients.12345Why are researchers excited about this trial?
Researchers are excited about the Health Information Exchange (HIE) platform because it aims to revolutionize how patient data is transferred between hospitals during patient transfers. Unlike current methods that often rely on cumbersome paper records or fragmented digital systems, the HIE platform facilitates a seamless electronic exchange of clinical information. This streamlined process is expected to enhance communication between hospitals, reduce delays, and improve overall patient care during transfers. By focusing on improving data accessibility and accuracy, the platform holds the promise of setting a new standard in patient transfer protocols.
What evidence suggests that this health information exchange platform is effective for improving patient transfers?
Research has shown that Health Information Exchange (HIE) platforms can enhance communication between hospitals. Studies have found that HIE systems reduce errors during patient transfers between hospitals. For example, one study found that HIE systems provide doctors with better information after a patient transfer. Another study showed that these systems can lower healthcare costs and improve outcomes for patients requiring additional care. In this trial, participants in the intervention arm will use an HIE platform to transfer clinical information, aiming to make hospital transfers safer and more efficient.23678
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are admitted to general medicine, cardiology, oncology, or ICU services at Brigham and Women's Hospital and transferred from one of these hospitals: Brigham and Women's Faulkner Hospital, South Shore Hospital, Milford Regional Medical Center. It excludes those under 18 or admitted through ER or directly from home/clinic.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
The baseline arm will include all included patient transfers from the 3 participating transfer hospitals to the 1 accepting hospital during the 1-year pre-intervention phase. They will not receive any intervention, but rather usual care.
Intervention
The intervention arm will include all included patient transfers from the 3 participating transfer hospitals to the 1 accepting hospital during the 1-year intervention phase. They will receive the intervention, which will include utilization of the developed health information exchange platform to transfer clinical information between transferring and accepting hospital.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including surveys of admitting clinicians 48-72 hours after patient transfer.
What Are the Treatments Tested in This Trial?
Interventions
- Health Information Exchange (HIE) platform
Find a Clinic Near You
Who Is Running the Clinical Trial?
Brigham and Women's Hospital
Lead Sponsor
Agency for Healthcare Research and Quality (AHRQ)
Collaborator